Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

BACKGROUND: Cryptococcal meningitis in HIV-infected patients in sub-Saharan Africa accounts for three-quarters of the global cases and 135,000 deaths per annum. Current treatment includes the use of fluconazole and amphotericin B. Recent evidence has shown that the synergistic use of flucytosine imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Miot, Jacqui, Leong, Trudy, Takuva, Simbarashe, Parrish, Andrew, Dawood, Halima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025344/
https://www.ncbi.nlm.nih.gov/pubmed/33823842
http://dx.doi.org/10.1186/s12913-021-06268-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025344/
https://www.ncbi.nlm.nih.gov/pubmed/33823842
http://dx.doi.org/10.1186/s12913-021-06268-9

Ejemplares similares